Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RIGL

Rigel Pharmaceuticals

May 29 • 04:00PM ET

30.49

+0.44 1.46 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NKTR BMRN INCY KRYS RYTM AXSM VKTX KYMR NUVL NBIX

| Held by: XBI AVUV VTI IWM VXF IWO IBB CALF SCHA FESM

Scroll to Statements

Index	RUT	P/E	1.63	EPS (ttm)	18.72	Insider Own	3.36%	Shs Outstand	18.48M	Perf Week	4.45%
Market Cap	564.13M	Forward P/E	6.97	EPS next Y	4.38	Insider Trans	-1.03%	Shs Float	17.88M	Perf Month	4.35%
Enterprise Value	463.17M	PEG	-	EPS next Q	0.21	Inst Own	93.14%	Short Float	22.07%	Perf Quarter	-12.23%
Income	364.23M	P/S	1.88	EPS this Y	-83.84%	Inst Trans	-1.32%	Short Ratio	9.93	Perf Half Y	-38.48%
Sales	299.77M	P/B	1.41	EPS next Y	38.98%	ROA	107.04%	Short Interest	3.95M	Perf YTD	-28.81%
Book/sh	21.64	P/C	3.85	EPS next 5Y	-	ROE	174.08%	52W High	52.24 -41.63%	Perf Year	56.12%
Cash/sh	7.93	P/FCF	7.12	EPS past 3/5Y	- -	ROIC	87.74%	52W Low	18.14 68.08%	Perf 3Y	130.98%
Dividend Est.	-	EV/EBITDA	3.65	Sales past 3/5Y	34.76% 22.06%	Gross Margin	93.39%	Volatility	3.31% 5.94%	Perf 5Y	-18.04%
Dividend TTM	-	EV/Sales	1.55	EPS Y/Y TTM	854.73%	Oper. Margin	41.56%	ATR (14)	1.55	Perf 10Y	23.94%
Dividend Ex-Date	-	Quick Ratio	2.48	Sales Y/Y TTM	47.61%	Profit Margin	121.51%	RSI (14)	56.28	Recom	1.80
Dividend Gr. 3/5Y	- -	Current Ratio	2.62	EPS Q/Q	-30.22%	SMA20	5.55%	Beta	1.19	Target Price	53.20
Payout	0.00%	Debt/Eq	0.11	Sales Q/Q	10.28%	SMA50	5.34%	Rel Volume	0.88	Prev Close	30.05
Employees	174	LT Debt/Eq	0.04	Earnings	May 05 AMC	SMA200	-12.01%	Avg Volume	397.50K	Price	30.49
IPO	Nov 29, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	-44.67% -5.73%	Trades		Volume	349,993	Change	1.46%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)